Cancer News and Research

Latest Cancer News and Research

BioInfect 2014 conference explores global anti-microbial agenda

This year’s unique BioInfect conference organised by Bionow, a not for profit membership organisation for the biomedical / life-sciences industry,was a major success.

10 Nov 2014

Effective treatment for phantom limb pain continues to be elusive

Army doctors in the First World War were helpless to stop soldiers who lost limbs from suffering in pain, according to researchers.

10 Nov 2014

Trover Campus wins 2014 Shining Star of Community Achievement award

The Trover Campus at Baptist Health Madisonville of the University of Louisville School of Medicine will receive the 2014 Shining Star of Community Achievement award from the Group on Regional Medical Campuses of the Association of American Medical Colleges.

9 Nov 2014

Worst effects of reperfusion injury after heart attack may be prevented with iodide

Blocked arteries are typically the trigger, stopping the flow of blood and starving the heart muscle of oxygen. But when the blockage is removed and the blood comes rushing back, it wreaks havoc of its own. The result is called reperfusion injury, a life-threatening flood of inflammation and cellular destruction that has stumped scientists for 40 years.

9 Nov 2014

Prof. Dan Peer awarded grant for groundbreaking development in cancer treatment

Prof. Dan Peer of Tel Aviv University's Department of Cell Research and Immunology will be awarded $10,000 for his groundbreaking development in cancer treatment at the inaugural Untold News Awards on Wednesday, November 12, 2014, from 6:00 to 8:00 p.m. at the Harmonie Club in New York City.

9 Nov 2014

Researchers find way to defeat elusive target proteins in cancer cells

Researchers at Dana-Farber/Boston Children's Cancer and Blood Disorders Center have found a way to defeat one of the most tantalizing yet elusive target proteins in cancer cells - employing a strategy that turns the protein's own molecular machinations against it.

9 Nov 2014

New vaccination approach can reduce tumor burden, suppress formation of lung metastases

In a new study published in the scientific journal Oncotarget researchers from Uppsala University show that a therapeutic vaccine directed against tumor vessels can reduce tumor burden and suppress formation of spontaneous lung metastases in a mouse model for metastatic breast cancer.

9 Nov 2014

Actimab-A extends overall survival, reduces bone marrow blasts in older AML patients

Interim data from an ongoing Phase I/II trial of Actimab-A, an innovative targeted payload immunotherapy, demonstrated a number of positive findings, including extension of overall survival and significant reductions in bone marrow blasts in older patients with newly diagnosed Acute Myeloid Leukemia (AML).

7 Nov 2014

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Eribulin (trade name: Halaven) is approved for women with locally advanced or metastatic breast cancer in whom the disease has progressed despite prior drug therapy. The German Institute for Quality and Efficiency in Health Care (IQWiG) examined in a dossier assessment whether the drug offers an added benefit over the appropriate comparator therapy in these patient groups.

7 Nov 2014

Neuronetrix selected to support upcoming ANAVEX 2-73 Phase 2a clinical trial

Neuronetrix has been selected by Anavex Life Sciences Corp. to support the upcoming Phase 2a clinical trial for ANAVEX 2-73, a symptomatic and potentially disease-modifying treatment for Alzheimer's disease. Neuronetrix will be utilizing their COGNISION System to measure and analyze cognitive biomarkers in study participants.

7 Nov 2014

Should we be screening for colorectal cancer earlier?

Colorectal cancer (CRC) is the third most commonly diagnosed cancer in men and women. Last year it was estimated that there had been around 143,000 new cases of CRC and 51,000 deaths due to CRC in the United States. The introduction of bowel screening for the over 50s has seen annual decreases in the overall incidence of CRC since 1998, giving cause for optimism.

7 Nov 2014

Surgical treatment of obesity, diabetes as safe as other commonly performed surgical procedures

Laparoscopic gastric bypass surgery in patients with type 2 diabetes, once considered a high-risk procedure, carries a complication and mortality rate comparable to some of the safest and most commonly performed surgeries in America, including gallbladder surgery, appendectomy, and total knee replacement, according to new research from the Cleveland Clinic Bariatric and Metabolic Institute.

7 Nov 2014

Health benefits of modified formulation of curcumin supplements

The health benefits of over-the-counter curcumin supplements might not get past your gut, but new research shows that a modified formulation of the spice releases its anti-inflammatory goodness throughout the body.

7 Nov 2014

Researchers obtain detailed picture of how Gas5 RNA interacts with steroid hormone receptors

It arises from what scientists previously described as "junk DNA" or "the dark matter of the genome," but this gene is definitely not junk.

7 Nov 2014

Seattle Children's starts patient enrollment for immunotherapy clinical trial for neuroblastoma

Seattle Children's today announced the opening of patient enrollment for its new cellular immunotherapy clinical research trial designed to induce remission in children suffering from neuroblastoma, one of the deadliest forms of childhood cancer.

7 Nov 2014

Applying lessons learnt from failed Alzheimer's studies for future research

Disappointing results in clinical Alzheimer's studies discourage doctors and scientists from continuing their research into ɣ-secretases and a possible treatment against Alzheimer's disease. In the prestigious journal Cell, the Alzheimer's expert Bart De Strooper (VIB-KU Leuven) argues that these studies are not pointless, but merely indicate what the next steps should be for the Alzheimer's research.

7 Nov 2014

Salk Institute researchers heal injured hearts of living mice

Researchers at the Salk Institute have healed injured hearts of living mice by reactivating long dormant molecular machinery found in the animals' cells, a finding that could help pave the way to new therapies for heart disorders in humans.

7 Nov 2014

Effective health interventions needed to increase life expectancy of older people

A major new Series on health and ageing, published in "The Lancet", warns that unless health systems find effective strategies to address the problems faced by an ageing world population, the growing burden of chronic disease will greatly affect the quality of life of older people. As people across the world live longer, soaring levels of chronic illness and diminished wellbeing are poised to become a major global public health challenge.

7 Nov 2014

Integrative medicine therapies can decrease pain, anxiety for hospitalized cancer patients

Pain is a common symptom of cancer and side effect of cancer treatment, and treating cancer-related pain is often a challenge for health care providers.

7 Nov 2014

Obeticholic acid improves liver health in people with nonalcoholic steatohepatitis

An experimental drug aimed at treating a common liver disease showed promising results and potential problems in a multicenter clinical trial funded by the National Institutes of Health. The FLINT study found that people with nonalcoholic steatohepatitis (NASH) who took obeticholic acid (OCA) had improved liver health during that period, including decreased inflammation and fat in the liver and decreased body weight versus people receiving a placebo. OCA was also associated with increases in itching and total cholesterol.

7 Nov 2014

Cancer News and Research

Latest Cancer News and Research

BioInfect 2014 conference explores global anti-microbial agenda

Effective treatment for phantom limb pain continues to be elusive

Trover Campus wins 2014 Shining Star of Community Achievement award

Worst effects of reperfusion injury after heart attack may be prevented with iodide

Prof. Dan Peer awarded grant for groundbreaking development in cancer treatment

Researchers find way to defeat elusive target proteins in cancer cells

New vaccination approach can reduce tumor burden, suppress formation of lung metastases

Actimab-A extends overall survival, reduces bone marrow blasts in older AML patients

Eribulin drug has minor added benefit in one patient group, indication of lesser benefit in others

Neuronetrix selected to support upcoming ANAVEX 2-73 Phase 2a clinical trial

Should we be screening for colorectal cancer earlier?

Surgical treatment of obesity, diabetes as safe as other commonly performed surgical procedures

Health benefits of modified formulation of curcumin supplements

Researchers obtain detailed picture of how Gas5 RNA interacts with steroid hormone receptors

Seattle Children's starts patient enrollment for immunotherapy clinical trial for neuroblastoma

Applying lessons learnt from failed Alzheimer's studies for future research

Salk Institute researchers heal injured hearts of living mice

Effective health interventions needed to increase life expectancy of older people

Integrative medicine therapies can decrease pain, anxiety for hospitalized cancer patients

Obeticholic acid improves liver health in people with nonalcoholic steatohepatitis

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Cancer News and Research

Latest Cancer News and Research

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Innovating Texture and Culture in Plant-Based Foods

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Newsletters you may be interested in